Endocrine, Metabolic & Immune Disorders - Drug Targets

Endocrine, Metabolic & Immune Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Back Subscribe
Review Article

The Potential of Natural Products in Metabolic Disease Management: A Thorough Exploration of the Case of Uganda

Author(s): Allan Amooti Ahikirizaorcid of author, Sarad Pawar Naik Bukke*orcid of author, Tadele Mekuriya Yadesaorcid of author, Buyinza Nicholas, Kasolo Daniel, Kabali Moses, Sewalu Mathias Bonny and Pranav Kumar Prabhakarauthors OrcID

Volume 25, Issue 12, 2025

Published on: 10 January, 2025

Page: [953 - 959] Pages: 7

DOI: 10.2174/0118715303320109241014064209

open_access

Become a Editorial Board Member
Become a Reviewer
Become a Editor
Become a Section Editor

Abstract

As Ugandans grapple with an increase in metabolic diseases, researchers are turning to their rich tradition of natural remedies. This review explores promising plants, such as Moringa oleifera, bridging the gap between the wisdom of Ugandan healers and modern science. Although these plants show potential, challenges remain. Many lack rigorous testing, standardized extracts, and long-term safety data. To unlock their true potential, a multipronged approach is needed. First, well-designed clinical trials are crucial to bringing together traditional healers and modern researchers. Imagine a Ugandan pharmacist precisely measuring a Moringa oleifera extract – this standardization ensures consistent results for future patients. Second, researchers need to delve deeper into how these plants influence the body. Finally, long-term safety studies are essential, especially when combined with medications. By following these steps, researchers can unleash the true power of Ugandan natural products. This empowers Ugandans to take control of their health. Future exploration of lesser-known plants and culturally sensitive education programs can further equip Ugandans on their way to well-being.

Keywords: Metabolic disease, natural product, ugandan healers, modern science, Moringa oleifera, health care routine.

Graphical Abstract

[1]
Hurtado, M.D.; Vella, A. What is type 2 diabetes? Medicine, 2019, 47, 10-5.
[2]
Tamel Selvan, K.; Goon, JA.; Makpol, S.; Tan, JK. Effects of microalgae on metabolic syndrome. Antioxidants, 2023, 12, 449.
[3]
IDF Diabetes Atlas; International Diabetes Federation, 2019. Available from: https://diabetesatlas.org/
[4]
Obakiro, S.B.; Kiyimba, K.; Lukwago, T.W.; Lulenzi, J.; Owor, R.O.; Andima, M.; Hokello, J.F.; Kawuma, C.; Nantale, G.; Kibuule, D.; Anywar, G.; Waako, P.; Gavamukulya, Y. Ethnobotanical study of plants used in management of diabetes mellitus in Eastern Uganda. Phytomedicine Plus, 2023, 3(4), 100486.
[http://dx.doi.org/10.1016/j.phyplu.2023.100486]
[5]
Padhi, S.; Nayak, A.K.; Behera, A. Type II diabetes mellitus: A review on recent drug based therapeutics. Biomed. Pharmacother., 2020, 131, 110708.
[http://dx.doi.org/10.1016/j.biopha.2020.110708] [PMID: 32927252]
[6]
Yu, B.; Tang, Q.; Fu, C.; Regenstein, J.; Huang, J.; Wang, L. Effects of different particle-sized insoluble dietary fibre from citrus peel on adsorption and activity inhibition of pancreatic lipase. Food Chem., 2023, 398, 133834.
[http://dx.doi.org/10.1016/j.foodchem.2022.133834] [PMID: 35961174]
[7]
Noncommunicable diseases; World Health Organization, 2023. Available from: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases
[8]
Eisenberg, D.M.; Davis, R.B.; Ettner, S.L.; Appel, S.; Wilkey, S.; Van Rompay, M.; Kessler, R.C. Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. JAMA, 1998, 280(18), 1569-1575.
[http://dx.doi.org/10.1001/jama.280.18.1569] [PMID: 9820257]
[9]
Fu, Y.S.; Chen, T.H.; Weng, L.; Huang, L.; Lai, D.; Weng, C.F. Pharmacological properties and underlying mechanisms of curcumin and prospects in medicinal potential. Biomed. Pharmacother., 2021, 141, 111888.
[http://dx.doi.org/10.1016/j.biopha.2021.111888] [PMID: 34237598]
[10]
Ekor, M. The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety. Front. Pharmacol., 2014, 4, 177.
[http://dx.doi.org/10.3389/fphar.2013.00177] [PMID: 24454289]
[11]
Rachitha, P.; Krishnaswamy, K.; Lazar, R.A.; Gupta, V.K.; Inbaraj, B.S.; Raghavendra, V.B.; Sharma, M.; Sridhar, K. Attenuation of hyperlipidemia by medicinal formulations of emblica officinalis synergized with nanotechnological approaches. Bioengineering (Basel), 2023, 10(1), 64.
[http://dx.doi.org/10.3390/bioengineering10010064] [PMID: 36671636]
[12]
Yang, A.; Lin, X.; Liu, Z.; Duan, X.; Yuan, Y.; Zhang, J.; Liang, Q.; Ji, X.; Sun, N.; Yu, H.; He, W.; Zhu, L.; Xu, B.; Lin, X. Worm generator: A system for high-throughput in vivo screening. Nano Lett., 2023, 23(4), 1280-1288.
[http://dx.doi.org/10.1021/acs.nanolett.2c04456] [PMID: 36719250]
[13]
Zengin, G.; Mollica, A.; Arsenijević, J.; Pavlić, B.; Zeković, Z.; Sinan, K.I.; Yan, L.; Cvetanović Kljakić, A.; Ražić, S. A comparative study of chamomile essential oils and lipophilic extracts obtained by conventional and greener extraction techniques: Chemometric approach to chemical composition and biological activity. Separations, 2022, 10(1), 18.
[http://dx.doi.org/10.3390/separations10010018]
[14]
Ahmed, O.A.A.; Hassan, N.A.; Azhar, A.S.; El-Mas, M.M.; El-Bassossy, H.M. A nano-pharmaceutical formula of quercetin protects from cardiovascular complications associated with metabolic syndrome. Front. Pharmacol., 2021, 12, 696981.
[http://dx.doi.org/10.3389/fphar.2021.696981] [PMID: 34456723]
[15]
Orhan, I.E. Pharmacognosy: Science of natural products in drug discovery. Bioimpacts, 2017, 4(3), 109-110.
[http://dx.doi.org/10.15171/bi.2014.001] [PMID: 25337461]
[16]
Walusansa, A.; Asiimwe, S.; Ssenku, J.E.; Anywar, G.; Namara, M.; Nakavuma, J.L.; Kakudidi, E.K. Herbal medicine used for the treatment of diarrhea and cough in Kampala city, Uganda. Trop. Med. Health, 2022, 50(1), 5.
[http://dx.doi.org/10.1186/s41182-021-00389-x] [PMID: 34991719]
[17]
Taweerutchana, R.; Lumlerdkij, N.; Vannasaeng, S.; Akarasereenont, P.; Sriwijitkamol, A. Effect of moringa oleifera leaf capsules on glycemic control in therapy-naïve type 2 diabetes patients: A randomized placebo controlled study. Evid. Based Complement. Alternat. Med., 2017, 2017(1), 6581390.
[http://dx.doi.org/10.1155/2017/6581390] [PMID: 29317895]
[18]
Szypowska, A.; Zatońska, K.; Szuba, A.; Regulska-Ilow, B. Dietary inflammatory index (DII)® and metabolic syndrome in the selected population of polish adults: Results of the pure poland sub-study. Int. J. Environ. Res. Public Health, 2023, 20(2), 1056.
[http://dx.doi.org/10.3390/ijerph20021056] [PMID: 36673811]
[19]
Sreejayan, N.; Rao, M.N. Free radical scavenging activity of curcuminoids. Arzneimittelforschung, 1996, 46(2), 169-171.
[PMID: 8720307]
[20]
Golzarand, M.; Omidian, M.; Toolabi, K. Effect of Garcinia cambogia supplement on obesity indices: A systematic review and dose-response meta-analysis. Complement. Ther. Med., 2020, 52, 102451.
[http://dx.doi.org/10.1016/j.ctim.2020.102451] [PMID: 32951714]
[21]
Hao, Z.; Zhang, Z.; Zhao, Y.; Wang, D. Baicalin reduces immune cell infiltration by inhibiting inflammation and protecting tight junctions in ischemic stroke injury. Am. J. Chin. Med., 2023, 51(2), 355-372.
[http://dx.doi.org/10.1142/S0192415X23500180] [PMID: 36661075]
[22]
Adaramoye, O.A.; Nwaneri, V.O.; Anyanwu, K.C.; Farombi, E.O.; Emerole, G.O. Possible anti-atherogenic effect of kolaviron (a Garcinia kola seed extract) in hypercholesterolaemic rats. Clin. Exp. Pharmacol. Physiol., 2005, 32(1-2), 40-46.
[http://dx.doi.org/10.1111/j.1440-1681.2005.04146.x] [PMID: 15730433]
[23]
Pi, J.; Wang, J.; Feng, X.; Li, Z.; Liu, Y.; Yang, W.; Zhang, T.; Guo, P.; Liu, Z.; Qi, D. The flavonoid components of scutellaria baicalensis: Biopharmaceutical properties and their improvement using nanoformulation techniques. Curr. Top. Med. Chem., 2023, 23(1), 17-29.
[http://dx.doi.org/10.2174/1568026623666221128144258] [PMID: 36443977]
[24]
Aziz, T.; Nadeem, A.A.; Sarwar, A.; Perveen, I.; Hussain, N.; Khan, A.A.; Daudzai, Z.; Cui, H.; Lin, L. Particle nanoarchitectonics for nanomedicine and nanotherapeutic drugs with special emphasis on nasal drugs and aging. Biomedicines, 2023, 11(2), 354.
[http://dx.doi.org/10.3390/biomedicines11020354] [PMID: 36830891]
[25]
Aditi, D.K.; Dabral, K. Role of essential oils and bioactive components for manufacturing cosmetic items. J. Res. Appl. Sci. Biotech., 2023, 2(1), 35-54.
[http://dx.doi.org/10.55544/jrasb.2.1.8]
[26]
Wang, Z.Q.; Ribnicky, D.; Zhang, X.H.; Zuberi, A.; Raskin, I.; Yu, Y.; Cefalu, W.T. An extract of Artemisia dracunculus L. enhances insulin receptor signaling and modulates gene expression in skeletal muscle in KK-Ay mice. J. Nutr. Biochem., 2011, 22(1), 71-78.
[http://dx.doi.org/10.1016/j.jnutbio.2009.11.015] [PMID: 20447816]
[27]
Wei, Z.; Pan, J.; Li, Y.; Artemisinin, G. Artemisinin G: A sesquiterpene from artemisia annua. Planta Med., 1992, 58(3), 300.
[http://dx.doi.org/10.1055/s-2006-961470] [PMID: 17226480]
[28]
Ivanescu, B.; Miron, A.; Corciova, A. Sesquiterpene lactones from artemisia genus: Biological activities and methods of analysis. J. Anal. Methods Chem., 2015, 2015, 1-21.
[http://dx.doi.org/10.1155/2015/247685] [PMID: 26495156]
[29]
Wang, Q.; Zhao, X.; Jiang, Y.; Jin, B.; Wang, L. Functions of representative terpenoids and their biosynthesis mechanisms in medicinal plants. Biomolecules, 2023, 13(12), 1725.
[http://dx.doi.org/10.3390/biom13121725] [PMID: 38136596]
[30]
Abad, M.J.; Bedoya, L.M.; Apaza, L.; Bermejo, P. The Artemisia L. Genus: A review of bioactive essential oils. Molecules, 2012, 17(3), 2542-2566.
[http://dx.doi.org/10.3390/molecules17032542] [PMID: 22388966]
[31]
Adetunji, C.O.; Michael, O.S.; Rathee, S.; Singh, K.R.B.; Ajayi, O.O.; Adetunji, J.B.; Ojha, A.; Singh, J.; Singh, R.P. Potentialities of nanomaterials for the management and treatment of metabolic syndrome: A new insight. Materials Today Advances, 2022, 13, 100198.
[http://dx.doi.org/10.1016/j.mtadv.2021.100198]
[32]
Hesari, M.; Mohammadi, P.; Khademi, F.; Shackebaei, D.; Momtaz, S.; Moasefi, N.; Farzaei, M.H.; Abdollahi, M. Current advances in the use of nanophytomedicine therapies for human cardiovascular diseases. Int. J. Nanomedicine, 2021, 16, 3293-3315.
[http://dx.doi.org/10.2147/IJN.S295508] [PMID: 34007178]
[33]
Cai, M.; Wang, Y.; Wang, R.; Li, M.; Zhang, W.; Yu, J.; Hua, R. Antibacterial and antibiofilm activities of chitosan nanoparticles loaded with Ocimum basilicum L. essential oil. Int. J. Biol. Macromol., 2022, 202, 122-129.
[http://dx.doi.org/10.1016/j.ijbiomac.2022.01.066] [PMID: 35041880]
[34]
Negri, G.; Calló, D.; Mano-Sousa, B.J.; Duarte-Almeida, J.M.; Carlini, E.A.; Tabach, R. Phytochemistry profile of rosella and jambolan extracts and the therapeutic effects on obesity. Food Funct., 2022, 13(5), 2606-2617.
[http://dx.doi.org/10.1039/D1FO02763H] [PMID: 35166751]
[35]
Davatgaran Taghipour, Y.; Hajialyani, M.; Naseri, R.; Hesari, M.; Mohammadi, P.; Stefanucci, A.; Mollica, A.; Farzaei, M.H.; Abdollahi, M. Nanoformulations of natural products for management of metabolic syndrome. Int. J. Nanomedicine, 2019, 14, 5303-5321.
[http://dx.doi.org/10.2147/IJN.S213831] [PMID: 31406461]
[36]
Goktas, Z.; Zu, Y.; Abbasi, M.; Galyean, S.; Wu, D.; Fan, Z.; Wang, S. Recent advances in nanoencapsulation of phytochemicals to combat obesity and its comorbidities. J. Agric. Food Chem., 2020, 68(31), 8119-8131.
[http://dx.doi.org/10.1021/acs.jafc.0c00131] [PMID: 32633507]
[37]
Rahman, M.M.; Islam, M.R.; Akash, S.; Harun-Or-Rashid, M.; Ray, T.K.; Rahaman, M.S.; Islam, M.; Anika, F.; Hosain, M.K.; Aovi, F.I.; Hemeg, H.A.; Rauf, A.; Wilairatana, P. Recent advancements of nanoparticles application in cancer and neurodegenerative disorders: At a glance. Biomed. Pharmacother., 2022, 153, 113305.
[http://dx.doi.org/10.1016/j.biopha.2022.113305] [PMID: 35717779]
[38]
Marton, L.T.; Pescinini-e-Salzedas, L.M.; Camargo, M.E.C.; Barbalho, S.M.; Haber, J.F.S.; Sinatora, R.V.; Detregiachi, C.R.P.; Girio, R.J.S.; Buchaim, D.V.; Cincotto dos Santos Bueno, P. The effects of curcumin on diabetes mellitus: A systematic review. Front. Endocrinol. (Lausanne), 2021, 12, 669448.
[http://dx.doi.org/10.3389/fendo.2021.669448] [PMID: 34012421]
[39]
Santos, F.H.; Panda, S.K.; Ferreira, D.C.M.; Dey, G.; Molina, G.; Pelissari, F.M. Targeting infections and inflammation through micro and nano-nutraceuticals. Food Biosci., 2022, 49, 101891.
[http://dx.doi.org/10.1016/j.fbio.2022.101891]
[40]
Li, R.; Zhan, W.; Huang, X.; Zhang, Z.; Zhou, M.; Bao, W.; Li, Q.; Ma, Y. Association of dietary inflammatory index and metabolic syndrome in the elderly over 55 years in Northern China. Br. J. Nutr., 2022, 128(6), 1082-1089.
[http://dx.doi.org/10.1017/S0007114521004207] [PMID: 34658314]
[41]
Obulesu, M. Turmeric and curcumin for neurodegenerative diseases, 1st ed; Elsevier: Waltham, 2021.
[42]
Bao, J.; Huang, B.; Zou, L.; Chen, S.; Zhang, C.; Zhang, Y.; Chen, M.; Wan, J.B.; Su, H.; Wang, Y.; He, C. Hormetic effect of berberine attenuates the anticancer activity of chemotherapeutic agents. PLoS One, 2015, 10(9), e0139298.
[http://dx.doi.org/10.1371/journal.pone.0139298] [PMID: 26421434]
[43]
Huang, D.; Wu, F.; Zhang, A.; Sun, H.; Wang, X. Efficacy of berberine in treatment of Rheumatoid arthritis: From multiple targets to therapeutic potential. Pharmacol. Res., 2021, 169, 105667.
[http://dx.doi.org/10.1016/j.phrs.2021.105667] [PMID: 33989762]
[44]
Xie, W.; Su, F.; Wang, G.; Peng, Z.; Xu, Y.; Zhang, Y.; Xu, N.; Hou, K.; Hu, Z.; Chen, Y.; Chen, R. Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis. Front. Pharmacol., 2022, 13, 1015045.
[http://dx.doi.org/10.3389/fphar.2022.1015045] [PMID: 36467075]
[45]
Ooi, C.P.; Yassin, Z.; Hamid, T.A. Momordica charantia for type 2 diabetes mellitus. Cochrane Libr., 2012, (8), CD007845.
[http://dx.doi.org/10.1002/14651858.CD007845.pub3] [PMID: 22895968]
[46]
Phytoantioxidants and nanotherapeutics; Rudrapal, M., Ed.; Wiley: Hoboken, NJ, 2023.
[47]
Sharifi-Rad, J.; Quispe, C.; Alfred, M.A.; Anil Kumar, N.V.; Lombardi, N.; Cinquanta, L.; Iriti, M.; Varoni, E.M.; Gupta, G.; Chellappan, D.K.; Dua, K.; Cardoso, S.M.; Peron, G.; Dey, A.; Cruz-Martins, N.; Rodrigues, C.F. Current trends on resveratrol bioactivities to treat periodontitis. Food Biosci., 2021, 42, 101205.
[http://dx.doi.org/10.1016/j.fbio.2021.101205]
[48]
Zhang, X.; Li, J.; Yang, B.; Leng, Q.; Li, J.; Wang, X.; Lu, J.; Olatunji, O.J.; Tang, J. Alleviation of liver dysfunction, oxidative stress, and inflammation underlines the protective effects of polysaccharides from Cordyceps cicadae on high sugar/high fat diet-induced metabolic syndrome in rats. Chem. Biodivers., 2021, 18(5), e2100065.
[http://dx.doi.org/10.1002/cbdv.202100065] [PMID: 33738897]
[49]
Krah, E.; de Kruijf, J.; Ragno, L. Integrating traditional healers into the health care system: Challenges and opportunities in rural northern ghana. J. Community Health, 2018, 43(1), 157-163.
[http://dx.doi.org/10.1007/s10900-017-0398-4] [PMID: 28681282]
[50]
Ssenku, J.E.; Okurut, S.A.; Namuli, A.; Kudamba, A.; Tugume, P.; Matovu, P.; Wasige, G.; Kafeero, H.M.; Walusansa, A. Medicinal plant use, conservation, and the associated traditional knowledge in rural communities in Eastern Uganda. Trop. Med. Health, 2022, 50(1), 39.
[http://dx.doi.org/10.1186/s41182-022-00428-1] [PMID: 35668541]
[51]
Bahloul, B.; Castillo-Henríquez, L.; Jenhani, L.; Aroua, N.; Ftouh, M.; Kalboussi, N.; Vega-Baudrit, J.; Mignet, N. Nanomedicine-based potential phyto-drug delivery systems for diabetes. J. Drug Deliv. Sci. Technol., 2023, 82, 104377.
[http://dx.doi.org/10.1016/j.jddst.2023.104377]
[52]
Mutola, S.; Pemunta, N.V.; Ngo, N.V. Utilization of traditional medicine and its integration into the healthcare system in Qokolweni, South Africa; prospects for enhanced universal health coverage. Complement. Ther. Clin. Pract., 2021, 43, 101386.
[http://dx.doi.org/10.1016/j.ctcp.2021.101386] [PMID: 33895465]
[53]
Kim, S.J.; Shah, F.H. Network pharmacology analysis with molecular docking of phytochemicals of Panax ginseng against osteosarcoma. Pharmacogn. Mag., 2022, 18(77), 175.
[http://dx.doi.org/10.4103/pm.pm_518_21]
[54]
Hosseini, H.; Ghavidel, F.; Panahi, G.; Majeed, M.; Sahebkar, A. A systematic review and meta-analysis of randomized controlled trials investigating the effect of the curcumin and piperine combination on lipid profile in patients with metabolic syndrome and related disorders. Phytother. Res., 2023, 37(3), 1212-1224.
[http://dx.doi.org/10.1002/ptr.7730] [PMID: 36649934]
[55]
Sadeghian, M.; Rahmani, S.; Jafarieh, A.; Jamialahmadi, T.; Sahebkar, A. The effect of curcumin supplementation on renal function: A systematic and meta-analysis of randomized controlled trials. J. Funct. Foods, 2023, 100, 105396.
[http://dx.doi.org/10.1016/j.jff.2022.105396]
[56]
Meng, T.; Wang, P.; Xie, X.; Li, T.; Kong, L.; Xu, Y.; Cao, K.; Gao, Y.; He, Q.; Lai, X. Efficacy and safety of Songling Xuemaikang capsule for essential hypertension: A systematic review and meta-analysis of randomized controlled trials. Phytomedicine, 2022, 107, 154459.
[http://dx.doi.org/10.1016/j.phymed.2022.154459] [PMID: 36183476]
[57]
Mishra, B.; Upadhyay, M.; Kumar, A. Role of nutraceuticals in metabolic syndrome. In: Drug Delivery Systems for Metabolic Disorders; Elsevier, 2022; pp. 459-467.
[http://dx.doi.org/10.1016/B978-0-323-99616-7.00033-5]
[58]
Mohd Zaid, N.A.; Sekar, M.; Bonam, S.R.; Gan, S.H.; Lum, P.T.; Begum, M.Y.; Mat Rani, N.N.I.; Vaijanathappa, J.; Wu, Y.S.; Subramaniyan, V.; Fuloria, N.K.; Fuloria, S. Promising natural products in new drug design, development, and therapy for skin disorders: An overview of scientific evidence and understanding their mechanism of action. Drug Des. Devel. Ther., 2022, 16, 23-66.
[http://dx.doi.org/10.2147/DDDT.S326332] [PMID: 35027818]
[59]
Yamagishi, Y.; Kudo, T.; Oyumi, M.; Sakamoto, Y.; Takahashi, K.; Akashi, T.; Kobayashi, S.; Kawakami, T.; Goda, H.; Sato, Y.; Mimaki, M.; Kodama, H.; Munakata, M.; Makino, K.; Takahashi, H.; Fukami, T.; Ito, K. Pharmacokinetics of CuGTSM, a novel drug candidate, in a mouse model of menkes disease. Pharm. Res., 2021, 38(8), 1335-1344.
[http://dx.doi.org/10.1007/s11095-021-03090-0] [PMID: 34403032]
[60]
Xu, J.; Lin, Q.; Sheng, M.; Ding, T.; Li, B.; Gao, Y.; Tan, Y. Antibiofilm effect of cinnamaldehyde-chitosan nanoparticles against the biofilm of Staphylococcus aureus. Antibiotics (Basel), 2022, 11(10), 1403.
[http://dx.doi.org/10.3390/antibiotics11101403] [PMID: 36290061]
[61]
Physical Exercise and Natural and Synthetic Products in Health and Disease; Guest, P.C., Ed.; Springer: Humana New York, NY, 2022.
[http://dx.doi.org/10.1007/978-1-0716-1558-4]
[62]
Yücel, Ç.; Şeker Karatoprak, G. Nanotechnology and phytonutrients. In: The Role of Phytonutrients in Metabolic Disorders; Elsevier, 2022; pp. 67-102.
[http://dx.doi.org/10.1016/B978-0-12-824356-5.00008-4]
[63]
Dias, M.; Romaní-Pérez, M.; Romaní, A.; de la Cruz, A.; Pastrana, L.; Fuciños, P.; Amado, I.R. Recent technological advances in phenolic compounds recovery and applications: Source of nutraceuticals for the management of diabetes. Appl. Sci. (Basel), 2022, 12(18), 9271.
[http://dx.doi.org/10.3390/app12189271]
[64]
Nurcahyanti, A.D.R.; Cokro, F.; Wulanjati, M.P.; Mahmoud, M.F.; Wink, M.; Sobeh, M. Curcuminoids for metabolic syndrome: Meta-analysis evidences toward personalized prevention and treatment management. Front. Nutr., 2022, 9, 891339.
[http://dx.doi.org/10.3389/fnut.2022.891339] [PMID: 35757255]
[65]
Qian, X.K.; Zhang, J.; Li, X.D.; Song, P.F.; Zou, L.W. Research progress on dipeptidyl peptidase family: Structure, function and xenobiotic metabolism. Curr. Med. Chem., 2022, 29(12), 2167-2188.
[http://dx.doi.org/10.2174/0929867328666210915103431] [PMID: 34525910]
[66]
Dewanjee, S.; Chakraborty, P.; Mukherjee, B.; De Feo, V. Plant-based antidiabetic nanoformulations: The emerging paradigm for effective therapy. Int. J. Mol. Sci., 2020, 21(6), 2217.
[http://dx.doi.org/10.3390/ijms21062217] [PMID: 32210082]
[67]
Fadel, H.H.M.; El-Ghorab, A.H.; Hussein, A.M.S.; El-Massry, K.F.; Lotfy, S.N.; Sayed Ahmed, M.Y.; Soliman, T.N. Correlation between chemical composition and radical scavenging activity of 10 commercial essential oils: Impact of microencapsulation on functional properties of essential oils. Arab. J. Chem., 2020, 13(8), 6815-6827.
[http://dx.doi.org/10.1016/j.arabjc.2020.06.034]
[68]
Gujar, K.; Wairkar, S. Nanocrystal technology for improving therapeutic efficacy of flavonoids. Phytomedicine, 2020, 71, 153240.
[http://dx.doi.org/10.1016/j.phymed.2020.153240] [PMID: 32450461]
[69]
Nouri, Z.; Hajialyani, M.; Izadi, Z.; Bahramsoltani, R.; Farzaei, M.H.; Abdollahi, M. Nanophytomedicines for the prevention of metabolic syndrome: A pharmacological and biopharmaceutical review. Front. Bioeng. Biotechnol., 2020, 8, 425.
[http://dx.doi.org/10.3389/fbioe.2020.00425] [PMID: 32478050]
[70]
Moradi, S.Z.; Momtaz, S.; Bayrami, Z.; Farzaei, M.H.; Abdollahi, M. Nanoformulations of herbal extracts in treatment of neurodegenerative disorders. Front. Bioeng. Biotechnol., 2020, 8, 238.
[http://dx.doi.org/10.3389/fbioe.2020.00238] [PMID: 32318551]
[71]
Das, A.; Saikia, R.; Pathak, K.; Gogoi, U.; Pathak, M.P. Anti-diabetic Nano-formulation from Herbal Source. In: Nano Medicine and Nano Safety; Das, M.K.; Pathak, Y.V., Eds.; Springer Singapore: Singapore, 2020; pp. 61-84.
[http://dx.doi.org/10.1007/978-981-15-6255-6_4]
[72]
Gang, R.; Matsabisa, M.; Okello, D.; Kang, Y. Ethnomedicine and ethnopharmacology of medicinal plants used in the treatment of diabetes mellitus in Uganda. Applied Biological Chemistry, 2023, 66(1), 39.
[http://dx.doi.org/10.1186/s13765-023-00797-z]
[73]
Gomes, M.A.; Manzano, C.; Alves, T.M.; Fiais, G.A.; Freitas, R.N.; Coutinho Mattera, M.S.L.; Dornelles, R.C.M.; Matsushita, D.H.; Stevanato Nakamune, A.C.M.; Chaves-Neto, A.H. Assessment of redox state and biochemical parameters of salivary glands in streptozotocin-induced diabetic male rats treated with mate tea (Ilex paraguariensis). Arch. Oral Biol., 2022, 143, 105551.
[http://dx.doi.org/10.1016/j.archoralbio.2022.105551] [PMID: 36167015]
[74]
Lin, H.C.; Lin, J.Y. Guava seed polysaccharides ameliorate the inflammatory status in PC-3 xenograft mice. Food Hydrocolloids for Health, 2022, 2, 100068.
[http://dx.doi.org/10.1016/j.fhfh.2022.100068]
[75]
Veiseh, O.; Tang, B.C.; Whitehead, K.A.; Anderson, D.G.; Langer, R. Managing diabetes with nanomedicine: Challenges and opportunities. Nat. Rev. Drug Discov., 2015, 14(1), 45-57.
[http://dx.doi.org/10.1038/nrd4477] [PMID: 25430866]